![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -1.72% | 14.25 | 14.00 | 14.50 | 14.25 | 14.00 | 14.00 | 1,152,228 | 11:56:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -11.05 | 134.53M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/7/2024 07:52 | Yes, these things happen in the real world. | ![]() ruckrover | |
23/7/2024 07:44 | Djokovic slips on your drivel ... a sad state and pulls out | ![]() inanaco | |
23/7/2024 07:37 | 99% probabilitySo NOT "no risk" then. You are predicting a 1% chance of failure. Based on what exactly? | ![]() ruckrover | |
23/7/2024 07:18 | Thanks for the info mate like i said for every buy there has to be a sell, how that is done depicts the movement, like tennis you only need a few extra points to win which is where we are now ..... the RNS we all seek will give us Lozan v Djokovic Scib1. bit one sided with a 99% probability | ![]() inanaco | |
22/7/2024 17:47 | Inan Those 500k sells that you call them are buys, the share price direction tells you that. It’s not necessarily someone supplying a 500k lump. EG X puts in an order for 500k, the broker fills the order by whatever means including multiple smaller buys available in the market. Typically the relevant broker sits on the bid. Once the order is filled whether it took hours or days, it gets reported to the market, typically mid price and in the unknown column. It’s perfectly legitimate under the rules for orders over the typical market size to be reported once they are complete. There is no fee for each buy hence you’ll see multiple apparently very small trades, it’s just a collection system for anything hitting the price. If selling 1 mill, 2 mill etc to a buyer that approached them that trade would appear as that amount once it’s completed, often double printed, shares in shares out, sometimes triple. As the price is rising it suggests buying in the market, order in, electronically sweeping up sells. Others buy (private investors) in rising prices. It all depends how many the buyer wants and what price they are willing to pay for them. It could be 10 mill then stop or the start of a large stake with plans to acquire Scancell. It’s not unreasonable to speculate a pharma is buying, given the patent cliffs for those in Melonoma sector with Scib so far blowing their treatments out of the water. Scancell could in theory, steal a $1.5 bill market right from under their noses. If Scancell do that, they potentially have the cash firepower to enhance patent cliff treatments with their platforms to become the standard of care. Redmile and Vulpes saw this coming long before the rest. If the data hits the mark (it should) other big funds wanting larger chunks are already waiting in the wings. Lindy mentioned that point in an interview. Interesting times ahead for investors and cancer sufferers. | ![]() chilltime | |
22/7/2024 16:21 | which is why i mentioned snapvax Modi1 | ![]() inanaco | |
22/7/2024 16:20 | yes Lindy is looking at that ,,,, “VAX-INNATE. | ![]() inanaco | |
22/7/2024 16:13 | Modi-2 will use SNAPvax to co-deliver homocitrullinated peptide antigens and TLR-7/8a adjuvants in self-assembling nanoparticles designed to prime tumor killing T cells. The company expects that the combination of Scancell’s Modi-2 with a highly effective platform for inducing T cells – Vaccitech’s SNAPvax technology – will lead to a potentially superior therapeutic vaccine candidate. SNAPvax not only primes and expands tumor-specific cytotoxic T cells that mediate tumor killing but also reverses suppression in the tumor microenvironment associated with significantly improved tumor regression | ![]() marcusl2 | |
22/7/2024 16:06 | Cavendish got his 36 the manx bullet | ![]() inanaco | |
22/7/2024 16:05 | Biden ........ dementia in charge of 1000's of nukes Bombs Putin ..... ukraine destroyed 🤷a | ![]() inanaco | |
22/7/2024 16:03 | England Cricket ... good stuff F1 ... sorted UK back on top ....... Verstappen proved to be a child Labour is losing control of budgets already | ![]() inanaco | |
22/7/2024 16:01 | news Nice weather just been out on the Kawasaki 600 | ![]() inanaco | |
22/7/2024 15:55 | Inan - happily have more than that and have passed some on to the Boys already. There's obviously LOTS going on. News please. | ![]() torquayfan | |
22/7/2024 15:51 | Gazza I dont give a toss .............. My account says ....🥂 | ![]() inanaco | |
22/7/2024 15:50 | Tf .. NO Risk was correct ......... £8 plus a share will be proven GF123 and you at least kept faith ! if you still have your 600,000 they will become very valuable and IMHO quite quickly 85% efficacy if it transpires is a serious number and easily calculated for probability on a market of $1.5b in sales per year with such a simple phase 2/3 trial i have no issues using the software i have found to predict outcomes also because of no safety issues | ![]() inanaco | |
22/7/2024 15:41 | "Not one of the "this is a risky share brigade" could answer"You still haven't fathomed the difference between "risky", "had risk" and "no risk"Ah well, never mind. Good to see the share price crawling out the depths though. | ![]() gazza | |
22/7/2024 15:39 | want a new patent on Modi1 ...... ? build a snapvax version | ![]() inanaco | |
22/7/2024 15:38 | Inan a nice nudge up again today. BTW some of your posts have been much appreciated on LSE as you might have seen. ATB R | ![]() torquayfan | |
22/7/2024 15:28 | it comes back to my no risk posts again, posted for years which one has failed Scib1 or Keytruda PD-1 Not one of the "this is a risky share brigade" could answer | ![]() inanaco | |
22/7/2024 15:23 | the science is already proven to work Both vaccine platforms induce a t cell response what your actually proving is how you can control the micro environment to give the t cells the best chance well Ctl-4 and Pd-1 have proven they can do that .... | ![]() inanaco | |
22/7/2024 15:15 | Does it really matter if people are buying and selling? The amount of times I've heard over the years the market makers are playing with the price. What matters here is the science and if it works or if it doesn't. | ![]() octopus100 | |
22/7/2024 13:33 | It’s often guesswork but some parts are known by certain investors and posters that does not get shared on public forums. EG a sell by a director some years ago went to an interesting individual. I’ve never seen them mentioned here. Sellers It’s often the case on long term holds that estate disposal situations can arise, I believe such a factor was around Scancell a few years back. Hence the guesswork point. Those working in the market get to see what shares went where, sells obvious as it’s a listed name or entity. New buyers can use routes to hide their true identity if they wish. I can see by recent posts certain topics are coming up where relatively tight rumours are in the background. The first port of call for any serious buyer in size is the broker contacting large holders to see if they will let any go. | ![]() chilltime | |
22/7/2024 12:44 | to be able to buy a share somebody needs to sell a share otherwise it all stops ..... these 500000 sells have fed the market ... when that seller is out .... shares could get very scarce on news Scancell has been around a long time and many have held and sold but they have memory of Scancell ..... if they look now they will be tempted for sure ..... | ![]() inanaco | |
22/7/2024 12:29 | Lots of continued buying pressure but no movement on price - that would suggest a seller (perhaps in recent placing) happy to offload. | ![]() nigelpm | |
22/7/2024 12:26 | Not Lozan, he is watching wood dry ..... | ![]() inanaco |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions